Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06635746
PHASE1
Dose Escalation Study of Vinpocetine in Healthy Volunteers
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
The objective of this study is to determine whether vinpocetine is safe when taken at higher doses.
Official title: Phase I, Open Label, Dose-Escalation Study for Maximum Tolerated Vinpocetine Dose in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-06-01
Completion Date
2026-06-01
Last Updated
2024-10-10
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Vinpocetine
Increasing doses of vinpocetine to assess tolerability.